Which vasopressor is the optimal first-line pressor to initiate in a hypotensive patient?

Norepinephrine is the First-Line Vasopressor

Norepinephrine should be initiated as the first-choice vasopressor in hypotensive patients requiring vasopressor support, targeting an initial mean arterial pressure (MAP) of 65 mmHg. This recommendation is based on strong, consistent evidence from the Surviving Sepsis Campaign guidelines 1, 2, 1.

Initial Vasopressor Selection

The evidence overwhelmingly supports norepinephrine as first-line therapy:

• Norepinephrine carries a strong recommendation with moderate quality evidence across all major guidelines 1, 2
• It demonstrates superior outcomes compared to dopamine, with lower mortality rates and fewer adverse effects including tachyarrhythmias 3, 4
• The α1-agonist properties effectively correct the vascular tone depression characteristic of vasodilatory shock 5, 6

Target Blood Pressure

Start with a MAP target of 65-70 mmHg 7:

• This threshold preserves tissue perfusion in most patients 3

• Higher MAP targets (>65 mmHg) should be considered in:

  • Patients with chronic arterial hypertension who show clinical improvement with higher pressures 1, 7
  • Patients with elevated central venous pressure (CVP) 7

• Lower MAP targets may be appropriate in:

  • Traumatic hemorrhagic shock with uncontrolled bleeding (systolic 80-90 mmHg or MAP 50-60 mmHg) without traumatic brain injury 7

Timing of Initiation

Do not delay norepinephrine until fluid resuscitation is complete 8:

• Early administration achieves MAP targets faster and reduces fluid overload risk 6
• Vasopressors should be administered simultaneously with fluid replacement to prevent and decrease duration of hypotension 9
• Diastolic arterial pressure (DAP) as a marker of vascular tone helps identify patients needing urgent norepinephrine 6

Alternative and Second-Line Agents

Dopamine should be reserved only for highly selected patients with:

• Low risk of tachyarrhythmias AND
• Absolute or relative bradycardia 1, 2

When norepinephrine alone is insufficient:

• Add vasopressin (0.03 units/min) to raise MAP to target or decrease norepinephrine dosage 1, 2
• Add epinephrine as an alternative second agent 1, 2
• Consider these additions when norepinephrine requirements become moderate rather than continuing to escalate norepinephrine doses 10

Phenylephrine is NOT recommended except in rare circumstances:

• Norepinephrine causes serious arrhythmias
• Cardiac output is known to be high with persistently low blood pressure
• As salvage therapy when other agents have failed 2

Common Pitfalls to Avoid

• Do not use low-dose dopamine for renal protection - this has strong evidence against it 1, 2, 1
• Do not use vasopressin as a single initial vasopressor - it should only be added to norepinephrine 1, 2
• Do not escalate norepinephrine indefinitely - consider adding a second agent when doses reach ≥1 µg/kg/min rather than continuing escalation 6
• Avoid excessive catecholamine exposure - this is associated with arrhythmias, ischemia, and poor outcomes 10

Monitoring

Place an arterial catheter as soon as practical in all patients requiring vasopressors 1, 2. Continuous arterial pressure monitoring is justified by hemodynamic instability and the need for repeated blood sampling 7.